THE EFFICACY AND SAFETY OF LEBRIKIZUMAB PLUS TOPICAL CORTICOSTEDOIDS IN MODERATETO SEVERE ATOPIC DERMATITIS. CDF [Internet]. 2024 Dec. 31 [cited 2026 Mar. 18];53(03):6987-93. Available from: https://cuestionesdefisioterapia.com/index.php/es/article/view/3988